Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: Evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency

European Journal of Nutrition

Volumn 51, Issue 1, 2012, Pages 1-18

  Ringseis, Robert ^a   Keller, Janine ^a   Eder, Klaus ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Carnitine; Glucose homeostasis; Insulin sensitivity; Type 2 diabetes

Indexed keywords

4 N TRIMETHYLAMINOBUTYRALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CARNITINE; GAMMA BUTYROBETAINE DIOXYGENASE; GLUCOSE; INSULIN; LEVACECARNINE; ORGANIC CATION TRANSPORTER 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE DEHYDROGENASE COMPLEX; SIBUTRAMINE; SOMATOMEDIN C; TETRAHYDROLIPSTATIN; UNCLASSIFIED DRUG; VALPROIC ACID;

CARNITINE DEFICIENCY; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HUMAN; HYPERAMMONEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER TOXICITY; LOW DRUG DOSE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; REVIEW; TREATMENT DURATION;

ACETYL COENZYME A; ANIMALS; BLOOD GLUCOSE; CARNITINE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE;

ANIMALIA;

EID: 84860668300     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0284-2     Document Type: Review

References (123)

1. Rebouche CJ, Seim H (1998) Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18:39-61 (Pubitemid 28366860)
2. Rebouche CJ, Bosch EP, Chenard CA, Schabold KJ, Nelson SE (1989) Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 119:1907-1913 (Pubitemid 20063884)
3. Lombard KA, Olson AL, Nelson SE, Rebouche CJ (1989) Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am J Clin Nutr 50:301-306 (Pubitemid 19208747)
4. Rebouche CJ (1992) Carnitine function and requirements during the life cycle. FASEB J 6:3379-3386 (Pubitemid 23007103)
5. Vaz FM, Wanders RJ (2002) Carnitine biosynthesis in mammals. Biochem J 361:417-429 (Pubitemid 34177810)
6. Davis AT (1999) Alterations in carnitine biosynthetic enzyme activities in carnitine deficient and carnitine supplemented rats. Experimental Biology'99, Washington, DC (Program addendum, abstract LB208)
7. Rebouche CJ, Chenard CA (1991) Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr 121:539-546
8. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382 (Pubitemid 28377603)
9. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072 (Pubitemid 32064631)
10. Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Cruse RP (1981) Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 31:819-825 (Pubitemid 11087098)
11. Harper P, Elwin CE, Cederblad G (1988) Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 35:555-562 (Pubitemid 18264762)
12. Sahajwalla CG, Helton ED, Purich ED, Hoppel CL, Cabana BE (1995) Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers. J Pharm Sci 84:627-633
13. Scaglia F, Wang Y, Longo N (1999) Functional characterization of the carnitine transporter defective in primary carnitine deficiency. Arch Biochem Biophys 364:99-106 (Pubitemid 29394296)
14. Kerner J, Hoppel C (2000) Fatty acid import into mitochondria. Biochim Biophys Acta 1486:1-17 (Pubitemid 30336788)
15. Mingorance C, Rodríguez-Rodríguez R, Justo ML, Alvarez de Sotomayor M, Herrera MD (2011) Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. Vasc Health Risk Manag 7:169-176
16. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7:45-56
17. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10:268-274 (Pubitemid 38667617)
18. Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM (2009) Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem 284:22840-22852
19. Derosa G, Maffioli P, Ferrari I, D'Angelo A, Fogari E, Palumbo I, Randazzo S, Cicero AF (2010) Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J 57:777-786
20. Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, D'Angelo A, Palumbo I, Randazzo S, Cicero AF (2010) Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med 49:1717-1725
21. Galloway SD, Craig TP, Cleland SJ (2011) Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males. Amino Acids 41:507-515
22. Bloomer RJ, Fisher-Wellman KH, Tucker PS (2009) Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics. Nutr Metab (Lond) 6:25
23. Liang Y, Yanbing L, Shan J, Yu B, Ho Z (1998) The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient. Asia Pac J Clin Nutr 7:192-195
24. Bowyer BA, Fleming CR, Haymond MW, Miles JM (1989) L-Carnitine: effect of intravenous administration on fuel homeostasis in normal subjects and home-parenteral-nutrition patients with low plasma carnitine concentrations. Am J Clin Nutr 49:618-623 (Pubitemid 19107280)
25. González-Ortiz M, Hernández-González SO, Hernández-Salazar E, Martínez-Abundis E (2008) Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Ann Nutr Metab 52:335-338
26. Malaguarnera M, Gargante MP, Russo C, Antic T, Vacante M, Malaguarnera M, Avitabile T, Li Volti G, Galvano F (2010) L-Carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial. Am J Gastroenterol 105:1338-1345
27. Mingrone G, Greco AV, Capristo E, Benedetti G, Giancaterini A, De Gaetano A, Gasbarrini G (1999) L-Carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr 18:77-82 (Pubitemid 29088689)
28. De Gaetano A, Mingrone G, Castagneto M, Calvani M (1999) Carnitine increases glucose disposal in humans. J Am Coll Nutr 18:289-295 (Pubitemid 29377187)
29. Angelini A, Imparato L, Landi C, Porfido FA, Ciarimboli M, Marro A (1993) Variation in levels of glycaemia and insulin after infusion of glucose solutions with or without added L-carnitine. Drugs Exp Clin Res 19:219-222 (Pubitemid 24029194)
30. Negro P, Gossetti F, La Pinta M, Mariani P, Carboni M (1994) The effect of L-carnitine, administered through intravenous infusion of glucose, on both glucose and insulin levels in healthy subjects. Drugs Exp Clin Res 20:257-262
31. Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B (2005) Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type 2 diabetes mellitus. Eur J Clin Nutr 59:592-596 (Pubitemid 40528674)
32. Molfino A, Cascino A, Conte C, Ramaccini C, Rossi Fanelli F, Laviano A (2010) Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism. JPEN J Parenter Enteral Nutr 34:295-299
33. Derosa G, Cicero AF, Gaddi A, Mugellini A, Ciccarelli L, Fogari R (2003) The effect of L-carnitine on plasma lipoprotein (a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 25:1429-1439 (Pubitemid 36677286)
34. Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL (1984) Improvement of myocardial function in diabetic rats after treatment with L-carnitine. Metabolism 33:358-363 (Pubitemid 14135356)
35. Power RA, Hulver MW, Zhang JY, Dubois J, Marchand RM, Ilkayeva O, Muoio DM, Mynatt RL (2007) Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia 50:824-832 (Pubitemid 46355838)
36. Dai T, Abou-Rjaily GA, Al-Share' QY, Yang Y, Fernström MA, Deangelis AM, Lee AD, Sweetman L, Amato A, Pasquali M, Lopaschuk GD, Erickson SK, Najjar SM (2004) Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. J Biol Chem 279:45155-45161 (Pubitemid 39430931)
37. Rodrigues B, Xiang H, McNeill JH (1988) Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37:1358-1364 (Pubitemid 19035986)
38. Mingorance C, Gonzalez del Pozo M, Dolores Herrera M, Alvarez de Sotomayor M (2009) Oral supplementation of propionyl-L-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats. Br J Nutr 102:1145-1153
39. Rajasekar P, Kaviarasan S, Anuradha CV (2005) L-Carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetol Croat 1:21-28 (Pubitemid 40942704)
40. Rajasekar P, Anuradha CV (2007) L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management. Acta Diabetol 44:83-90 (Pubitemid 46835450)
41. Rajasekar P, Viswanathan P, Anuradha CV (2008) Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. Diabetes Obes Metab 10:171-180
42. Yoshikawa Y, Ueda E, Sakurai H, Kojima Y (2003) Anti-diabetes effect of Zn (II)/carnitine complex by oral administration. Chem Pharm Bull (Tokyo) 51:230-231 (Pubitemid 41702003)
43. Broderick TL, Quinney HA, Lopaschuk GD (1992) Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267:3758-3763
44. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD (1993) Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 87:972-981 (Pubitemid 23070829)
45. Broderick TL, Quinney HA, Lopaschuk GD (1995) L-Carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res 29:373-378
46. Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL, Paulson DJ (1995) L-Carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res 30:815-820
47. Schönekess BO, Allard MF, Lopaschuk GD (1995) Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 77:726-734
48. Schönekess BO, Allard MF, Lopaschuk GD (1995) Propionyl L-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency. Eur J Pharmacol 286:155-166
49. Broderick TL, Driedzic W, Paulson DJ (2000) Propionyl-L-carnitine effects on postischemic recovery of heart functionand substrate oxidation in the diabetic rat. Mol Cell Biochem 206:151-157 (Pubitemid 30246517)
50. Broderick TL, Haloftis G, Paulson DJ (1996) L-Propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. J Mol Cell Cardiol 28:331-340 (Pubitemid 26110477)
51. Broderick TL (2008) ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart. Drugs R D 9:83-91 (Pubitemid 351313819)
52. Felix C, Gillis M, Driedzic WR, Paulson DJ, Broderick TL (2001) Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diabetes Res Clin Pract 53:17-24 (Pubitemid 32506896)
53. Neely JR, Morgan HE (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36:413-459
54. Wall SR, Lopaschuk GD (1989) Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1006:97-103 (Pubitemid 19264816)
55. Chatham JC, Forder JR (1997) Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol 273:H52-H58
56. Nicholl TA, Lopaschuk GD, McNeill JH (1991) Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart. Am J Physiol 261:H1053-H1059
57. Hotta K, Kuwajima M, Ono A, Nakajima H, Horikawa Y, Miyagawa J, Namba M, Hanafusa T, Horiuchi M, Nikaido H, Hayakawa J, Saheki T, Kono N, Noguchi T, Matsuzawa Y (1996) Disordered expression of glycolytic and gluconeogenic liver enzymes of juvenile visceral steatosis mice with systemic carnitine deficiency. Diabetes Res Clin Pract 32:117-123 (Pubitemid 26228395)
58. Ringseis R, Mooren FC, Keller J, Couturier A, Wen G, Hirche F, Stangl GI, Eder K, Krüger K (2011) Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high fat diet. Mol Nutr Food Res 55:S193-S202
59. Cuturic M, Abramson RK, Moran RR, Hardin JW (2011) Carnitine and metabolic correlates in hospitalized psychiatric patients: a follow-through report. J Psychiatr Pract 17:35-40
60. Ushikai M, Horiuchi M, Kobayashi K, Matuda S, Inui A, Takeuchi T, Saheki T (2011) Induction of PDK4 in the heart muscle of JVS mice, an animal model of systemic carnitine deficiency, does not appear to reduce glucose utilization by the heart. Mol Genet Metab 102:349-355
61. Nakajima H, Kodo N, Inoue F, Kizaki Z, Nukina S, Kinugasa A, Sawada T (1996) Pivalate affects carnitine status but causes no severe metabolic changes in rat liver. J Nutr 126:1683-1687 (Pubitemid 26182402)
62. Broderick TL, Christos SC, Wolf BA, DiDomenico D, Shug AL, Paulson DJ (1995) Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. Metabolism 44:499-505
63. Liepinsh E, Vilskersts R, Skapare E, Svalbe B, Kuka J, Cirule H, Pugovics O, Kalvinsh I, Dambrova M (2008) Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart. Life Sci 83:613-619
64. Liepinsh E, Vilskersts R, Zvejniece L, Svalbe B, Skapare E, Kuka J, Cirule H, Grinberga S, Kalvinsh I, Dambrova M (2009) Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats. Br J Pharmacol 157:1549-1556
65. Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M (2011) Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol 658:277-283
66. Krähenbühl S, Mang G, Kupferschmidt H, Meier PJ, Krause M (1995) Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity. Gut 37:140-143
67. Lheureux PE, Penaloza A, Zahir S, Gris M (2005) Science review: carnitine in the treatment of valproic acid-induced toxicity-what is the evidence? Crit Care 9:431-440 (Pubitemid 41498538)
68. Horiuchi M, Kobayashi K, Yamaguchi S, Shimizu N, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M, Saheki T (1994) Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim Biophys Acta 1226:25-30 (Pubitemid 24123051)
69. Holme E, Greter J, Jacobson CE, Lindstedt S, Nordin I, Kristiansson B, Jodal U (1989) Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 2:469-473 (Pubitemid 19209142)
70. Luci S, Geissler S, König B, Koch A, Stangl GI, Hirche F, Eder K (2006) PPARalpha agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 350:704-708 (Pubitemid 44547904)
71. Van Vlies N, Ferdinandusse S, Turkenburg M, Wanders RJ, Vaz FM (2007) PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta 1767:1134-1142 (Pubitemid 47313393)
72. Koch A, König B, Stangl GI, Eder K (2008) PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp Biol Med (Maywood) 233:356-365 (Pubitemid 351328577)
73. Ringseis R, Eder K (2009) Influence of pharmacological PPARα activators on carnitine homeostasis in proliferating and nonproliferating species. Pharmacol Res 60:179-184
74. Ringseis R, Wege N, Wen G, Rauer C, Hirche F, Kluge H, Eder K (2009) Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species. J Nutr Biochem 20:840-847
75. Wen G, Ringseis R, Eder K (2010) Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor α (PPARα) via a PPRE located in the first intron. Biochem Pharmacol 79:768-776
76. Wen G, Kühne H, Rauer C, Ringseis R, Eder K (2011) Mouse γ-butyrobetaine dioxygenase is regulated by peroxisome proliferator-activated receptor a through a PPRE located in the proximal promoter. Biochem Pharmacol 82:175-183
77. Dambrova M, Liepinsh E, Kalvinsh I (2002) Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12:275-279 (Pubitemid 35286766)
78. Asaka N, Muranaka Y, Kirimoto T, Miyake H (1998) Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts. Fundam Clin Pharmacol 12:158-163 (Pubitemid 28154604)
79. Spaniol M, Kaufmann P, Beier K, Wüthrich J, Török M, Scharnagl H, März W, Krähenbühl S (2003) Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J Lipid Res 44:144-153 (Pubitemid 36114780)
80. Kuka J, Vilskersts R, Cirule H, Makrecka M, Pugovics O, Kalvinsh I, Dambrova M, Liepinsh E (2011) The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine. J Cardiovasc Pharmacol Ther. doi:10.1177/107424841 1419502
81. Borum PR, Broquist HP (1977) Lysine deficiency and carnitine in male and female rats. J Nutr 107:1209-1215 (Pubitemid 8146407)
82. Cave MC, Hurt RT, Frazier TH, Matheson PJ, Garrison RN, McClain CJ, McClave SA (2008) Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract 23:16-34 (Pubitemid 351438965)
83. Pregant P, Kaiser E, Schernthaner G (1993) No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients. Clin Investig 71:610-612 (Pubitemid 23240603)
84. Okuda Y, Kawai K, Murayama Y, Yamashita K (1987) Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin-dependent diabetic subjects. Endocrinol Jpn 34:415-422 (Pubitemid 17137008)
85. De Palo E, Gatti R, Sicolo N, Padovan D, Vettor R, Federspil G (1981) Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetol Lat 18:91-95 (Pubitemid 11158431)
86. Winter SC, Simon M, Zorn EM, Szabo-Aczel S, Vance WH, O'Hara T, Higashi L (1989) Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child 143:1337-1339 (Pubitemid 19266172)
87. Poorabbas A, Fallah F, Bagdadchi J, Mahdavi R, Aliasgarzadeh A, Asadi Y, Koushavar H, Vahed Jabbari M (2007) Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 61:892-895 (Pubitemid 47040313)
88. Tamamoǧullari N, Siliǧ Y, Içaǧasioǧlu S, Atalay A (1999) Carnitine deficiency in diabetes mellitus complications. J Diabetes Complicat 13:251-253 (Pubitemid 30182604)
89. Pregant P, Schernthaner G, Legenstein E, Lienhart L, Bruck S, Schnack C, Kaiser E (1991) Decreased plasma carnitine in type I diabetes mellitus. Klin Wochenschr 69:511-516
90. Soltész G, Melegh B, Sándor A (1983) The relationship between carnitine and ketone body levels in diabetic children. Acta Paediatr Scand 72:511-515 (Pubitemid 13062861)
91. McGarry JD, Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14 (Pubitemid 27079689)
92. Steiber A, Kerner J, Hoppel CL (2004) Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25:455-473 (Pubitemid 39195071)
93. Uziel G, Garavaglia B, Di Donato S (1988) Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11:720-724
94. Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL (1988) Quantitation of the effect of L-carnitine on the levels of acidsoluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263:1151-1156 (Pubitemid 18039914)
95. Ramsay RR, Zammit VA (2004) Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 25:475-493 (Pubitemid 39195072)
96. Giancaterini A, De Gaetano A, Mingrone G, Gniuli D, Liverani E, Capristo E, Greco AV (2000) Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49:704-708 (Pubitemid 30354575)
97. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL (2006) An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle. J Clin Endocrinol Metab 91:5013-5018 (Pubitemid 44917343)
98. Wyss V, Ganzit GP, Rienzi A (1990) Effects of L-carnitine administration on VO2max and the aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol Occup Physiol 60:1-6 (Pubitemid 20056254)
99. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F (1988) Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255:E946-E952
100. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL (2005) Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 20:377-379
101. Clausen T (2003) Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83:1269-1324 (Pubitemid 37222273)
102. Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, Orisio S, Remuzzi G (2009) Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension 54:567-574
103. Zhou YP, Ling ZC, Grill VE (1996) Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. Metabolism 45:981-986 (Pubitemid 26282551)
104. Keller K, Ringseis R, Priebe S, Guthke R, Kluge H, Eder K (2011) Transcript profiling in the liver of piglets fed L-carnitine. Nutr Metab (Lond) 8:76
105. Rajasekar P, Anuradha CV (2007) Fructose-induced hepatic gluconeogenesis: effect of L-carnitine. Life Sci 80:1176-1183 (Pubitemid 46329009)
106. Proulx F, Lacroix J, Qureshi IA, Nadeau D, Gauthier M, Lambert M (1997) Acquired carnitine abnormalities in critically ill children. Eur J Pediatr 156:864-869 (Pubitemid 27463133)
107. Newsholme P, Brennan L, Rubi B, Maechler P (2005) New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond) 108:185-194 (Pubitemid 40343565)
108. Heo YR, Kang CW, Cha YS (2001) L-Carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streptozotocin-induced diabetic rat. J Nutr Sci Vitaminol (Tokyo) 47:329-334
109. Keller J, Ringseis R, Priebe S, Guthke R, Kluge H, Eder K (2011) Dietary L-carnitine alters gene expression in skeletal muscle of piglets. Mol Nutr Food Res 55:419-429
110. Kita K, Kato S, Amanyaman M, Okumura J, Yokota H (2002) Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level. Br Poult Sci 43:117-121 (Pubitemid 135746464)
111. Doberenz J, Birkenfeld C, Kluge H, Eder K (2006) Effects of L-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics. J Anim Physiol Anim Nutr 90:487-499 (Pubitemid 44682075)
112. Di Marzio L, Moretti S, D'Alò S, Zazzeroni F, Marcellini S, Smacchia C, Alesse E, Cifone MG, De Simone C (1999) Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation. Clin Immunol 92:103-110 (Pubitemid 29315991)
113. Musser RE, Goodband RD, Tokach MD, Owen KQ, Nelssen JL, Blum SA, Campbell RG, Smits R, Dritz SS, Civis CA (1999) Effects of L-carnitine fed during lactation on sow and litter performance. J Anim Sci 77:3289-3295 (Pubitemid 129545883)
114. Ramanau A, Kluge H, Spilke J, Eder K (2002) Reproductive performance of sows supplemented with dietary L-carnitine over three reproductive cycles. Arch Anim Nutr 56:287-296
115. Ramanau A, Kluge H, Spilke J, Eder K (2004) Supplementation of sows with L-carnitine during pregnancy and lactation improves growth of the piglets during the suckling period through increased milk production. J Nutr 134:86-92 (Pubitemid 38057428)
116. Kelley RL, Jungst SB, Spencer TE, Owsley WF, Rahe CH, Mulvaney DR (1995) Maternal treatment with somatotropin alters embryonic development and early postnatal growth of pigs. Domest Anim Endocrinol 12:83-94
117. Baumann MU, Deborde S, Illsley NP (2002) Placental glucose transfer and fetal growth. Endocrine 19:13-22 (Pubitemid 36106249)
118. Waber LJ, Valle D, Neill C, DiMauro S, Shug A (1982) Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr 101:700-705
119. Glasgow AM, Engel AG, Bier DM, Perry LW, Dickie M, Todaro J, Brown BI, Utter MF (1983) Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res 17:319-326 (Pubitemid 13135211)
120. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RJ, Shug AL (1981) Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med 305:385-390 (Pubitemid 11063755)
121. Tassani V, Cattapan F, Magnanimi L, Peschechera A (1994) Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Biochem Biophys Res Commun 199:949-953 (Pubitemid 24181754)
122. Capaldo B, Napoli R, Di Bonito P, Albano G, Saccà L (1991) Carnitine improves peripheral glucose disposal in non-insulindependent diabetic patients. Diabetes Res Clin Pract 14:191-195
123. Günal AI, Celiker H, Dönder E, Günal SY (1999) The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol 12:38-40 (Pubitemid 29130703)